Hikma exceeds 150 injectable medicines in the US with launch of Dobutamine Injection, USP
/PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, has launched Dobutamine Injection, USP, in a 250mg/20mL vial in...
Source: prnewswire.com